A share price of Perspective Therapeutics Inc [CATX] is currently trading at $12.70, up 0.40%. An important factor to consider is whether the stock is rising or falling in short-term value. The CATX shares have gain 3.34% over the last week, with a monthly amount drifted -4.01%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Perspective Therapeutics Inc [AMEX: CATX] stock has seen the most recent analyst activity on October 01, 2024, when Wedbush initiated its Outperform rating and assigned the stock a price target of $25. Previously, Truist started tracking the stock with Buy rating on September 25, 2024, and set its price target to $21. On July 25, 2024, BofA Securities initiated with a Buy rating and assigned a price target of $24 on the stock. Cantor Fitzgerald started tracking the stock assigning a Overweight rating.
Perspective Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $2.20 and $19.05. Currently, Wall Street analysts expect the stock to reach $17.5 within the next 12 months. Perspective Therapeutics Inc [AMEX: CATX] shares were valued at $12.70 at the most recent close of the market. An investor can expect a potential return of 37.8% based on the average CATX price forecast.
Analyzing the CATX fundamentals
Trailing Twelve Months sales for Perspective Therapeutics Inc [AMEX:CATX] were 8.84M which represents -74.50% decline. Gross Profit Margin for this corporation currently stands at 0.04% with Operating Profit Margin at -6.43%, Pretax Profit Margin comes in at -6.21%, and Net Profit Margin reading is -6.3%. To continue investigating profitability, this company’s Return on Assets is posted at -0.19, Equity is -0.21 and Total Capital is -0.21. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 12.45 points at the first support level, and at 12.21 for the second support level. However, for the 1st resistance point, the stock is sitting at 12.89, and for the 2nd resistance point, it is at 13.09.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Perspective Therapeutics Inc [AMEX:CATX] is 27.73. On the other hand, the Quick Ratio is 27.73, and the Cash Ratio is 2.22. Considering the valuation of this stock, the price to sales ratio is 96.87, the price to book ratio is 2.51.
Transactions by insiders
Recent insider trading involved Mark Austin, affiliate, that happened on Sep 12 ’24 when 2500.0 shares were purchased. Chief Financial Officer, Hunt Jonathan Robert completed a deal on Jun 17 ’24 to buy 1800.0 shares. Meanwhile, Director Woods Lori A bought 4587.0 shares on Jun 14 ’24.
